💊
ANTIRETROVIRAL WHO Essential Verified Rx Required
Tenofovir/Lamivudine/Dolutegravir
Also known as:TLDTriumeq "TLD"
1 Protocols
2 views
Primary Use
First-line HIV treatment regimen.
Also Used For:
HIV post-exposure prophylaxis
Drug Classification
Medication Type
ANTIRETROVIRAL
Drug Class
INSTI-based combination
Dosage & Administration
Standard Dosage
300mg/300mg/50mg
Frequency
Once daily
Duration
Long-term treatment
Route
ORAL
Best Time
Same time every day
Important
Can take with or without food
Available Forms
Dosage Forms
TABLET
Available Strengths
300mg/300mg/50mg
Appearance
Pink oval tablet
Effectiveness
Success Rate
95%+ viral suppression rate
High genetic barrier to resistance. Preferred first-line regimen globally.
Treatment Protocols
HIV Treatment - First-Line ART (TLD)
For: HIV
Dosage
1 tablet (TDF 300mg / 3TC 300mg / DTG 50mg)
Frequency
Once daily
Duration
Lifelong
95%+ viral suppression rate. U=U: Undetectable = Untransmittable
Safety Information
Common Side Effects
InsomniaHeadacheNauseaDizziness
Serious Side Effects (Seek Medical Help)
Hypersensitivity reaction
Liver problems
Mental health effects
Contraindications (Do Not Use If)
Dolutegravir allergy
Concurrent dofetilide use
Drug Interactions
AntacidsIron supplementsCalcium supplementsCertain anticonvulsants
Pregnancy
Category B - Recommended first-line in pregnancy
Breastfeeding
Compatible with breastfeeding
Pricing Information
Mfg. Cost
$20
Global Avg. Price
$75
Patent Status
Brand and generic available
Prices may vary significantly by country, pharmacy, and insurance coverage. This is an average estimate.
Availability & Regulations
Prescription Required
Not OTC
Not Controlled
FDA Approval
2014
Available In
🇵🇭Philippines🇹🇭Thailand🇻🇳Vietnam🇸🇬Singapore🇲🇾Malaysia🇺🇸United States🇬🇧United Kingdom